 Home > Active Ingredient News > Antitumor Therapy > European Radiology: Lineage plot of survival prognosis for triple-negative breast cancer

European Radiology: Lineage plot of survival prognosis for triple-negative breast cancer

 Last Update: 2022-10-12
 Source: Internet
 Author: User

Tags

amphetamine 20 mg

cancer cell international

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Triple-negative breast cancer (TNBC) is a type of breast cancer molecule that is negatively expressed by estrogen receptors (ER), progesterone receptors (PRs), and human epidermal growth factor receptor-2 (HER-2), accounting for approximately 15% to 20%

Studies have found that a number of clinicopathological factors, including age at diagnosis, positive status of axillary lymph nodes, lymphatic infiltration (LVI), and histological grade, are associated

At present, imaging techniques such as magnetic resonance imaging (MRI), molybdenum target (MG) and ultrasound (US) have been widely used in preoperative diagnostic techniques

Recently, a study published in the European Journal of Radiology predicted the clinicopathological and mammography features associated with TNBC survival prognosis, and developed and validated an effective predictive laminography model to assess TNBC prognosis, providing technical support

This study conducted a retrospective evaluation

A total of 636 TNBC patients were enrolled and divided into training cohorts (n=446) and validation cohorts (n=190

In this study, clinical factors including tumor size >2 cm, axillary lymphadenectomy, presence of LVI, absence of adjuvant postoperative chemotherapy, axillary lymph node load (≥ 4 positive lymph nodes), and malignant sonogram features are all associated

Original source:

Dan-Li Sheng,Xi-Gang Shen,Zhao-Ting Shi,et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

High Quality Resveratrol 99% powder 501-36-0 Shaanxi Dideu Medichem Co.Ltd

CAS No.: 501-36-0

Chemical Grade

$1/KG FOB

High purity Epirubicin hydrochloride 98% with best price 56390-09-1 and Epirubicin hydrochloride raw powder

CAS No.: 56390-09-1

Pharmacy Grade

$8.8-10/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.